April 10, 2008


FDA Public Hearing on Antimicrobial Resistance

The Food and Drug Administration (FDA) is announcing a public hearing on antimicrobial resistance. FDA is seeking general information about the problem of antimicrobial resistance, recommendations as to possible approaches to contain the problem of antimicrobial resistance, responses to specific questions, and other pertinent information from interested parties. In addition, interested parties may provide views on which serious and life-threatening infectious diseases, such as diseases due to gram-negative bacteria and other diseases due to antimicrobial-resistant bacteria, potentially qualify for available grants and contracts or other development incentives.

The public hearing will be held on Monday, April 28, 2008, from 8:00 a.m. to 5:00 p.m. at the University System of Maryland Shady Grove Center, 9630 Gudelsky Drive, Rockville, MD 20850. Written or electronic notices of participation should be submitted by the close of business on Monday, April 21, 2008. Written or electronic comments will be accepted until Monday, May 26, 2008.

The attached Federal Register notice provides more detailed information about the logistics and process for participation at this hearing. The attached notice also includes issues for discussion which includes specific questions for which FDA invites comments from interested parties (please see Section III on page 6 of the attached Federal Register notice).